.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Fuji
Federal Trade Commission
Covington
Healthtrust
UBS
Chinese Patent Office
Johnson and Johnson
Queensland Health
Chubb

Generated: June 28, 2017

DrugPatentWatch Database Preview

Ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for ibuprofen and what is the scope of ibuprofen patent protection?

Ibuprofen
is the generic ingredient in forty-four branded drugs marketed by Amneal Pharms, J And J Consumer Inc, Ani Pharms Inc, Bayer, Pfizer, Moberg Pharma North, Vintage Pharms, Marksans Pharma, Watson Labs, Sandoz, Sun Pharm Inds, Superpharm, LNK, Dr Reddys Labs Inc, Granules India Ltd, Aiping Pharm Inc, Perrigo R And D, Ohm Labs, Mcneil, Actavis Mid Atlantic, L Perrigo Co, Mcneil Ped, Purepac Pharm, Halsey, Par Pharm, Lederle, Strides Pharma, Contract Pharmacal, Northstar Hlthcare, Wyeth Cons, Amneal Pharms Ny, Bristol Myers, Aurolife Pharma Llc, Perrigo, P And L Dev Llc, Ivax Sub Teva Pharms, Teva, Mcneil Consumer, Basf, Mylan Pharms Inc, Hi-tech Pharmacal, Cumberland Pharms, Abbott, Alra, Mylan, Tris Pharma Inc, Avema Pharma, Dr Reddys La, OHM, Leiner, Pliva, Humanwell Puracap, Bionpharma Inc, Granules India, Merro Pharm, Sofgen Pharms, Exela Pharma Science, Recordati Rare, Pfizer Cons Hlthcare, Barr Labs Inc, Actavis Elizabeth, Forest Labs, and Dr Reddys Labs Ltd, and is included in two hundred and one NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ibuprofen has thirty-nine patent family members in eleven countries.

There are sixty-three drug master file entries for ibuprofen. Two hundred and fifty-four suppliers are listed for this compound.

Summary for Generic Name: ibuprofen

Tradenames:44
Patents:13
Applicants:63
NDAs:201
Drug Master File Entries: see list63
Suppliers / Packagers: see list254
Bulk Api Vendors: see list119
Clinical Trials: see list503
Patent Applications: see list9,694
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ibuprofen at DailyMed

Pharmacology for Ingredient: ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Ny
IBUPROFEN
ibuprofen
TABLET;ORAL071334-001Nov 25, 1986ABRXNoNo► Subscribe► Subscribe
Perrigo R And D
IBUPROFEN
ibuprofen
TABLET;ORAL077114-003Jul 18, 2005ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Inc
IBUPROFEN
ibuprofen
TABLET;ORAL076112-002Oct 31, 2001ABRXNoNo► Subscribe► Subscribe
Halsey
IBUPROFEN
ibuprofen
TABLET;ORAL072137-001Feb 5, 1988DISCNNoNo► Subscribe► Subscribe
Mcneil
IBUPROFEN
ibuprofen
TABLET;ORAL073019-001Mar 30, 1994OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
SUSPENSION;ORAL020516-001Jun 16, 19955,374,659*PED► Subscribe
Pfizer
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL020589-001Jun 27, 19964,788,220*PED► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 19945,215,755*PED► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020601-001Nov 15, 19965,215,755*PED► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
SUSPENSION/DROPS;ORAL020603-001Jun 10, 19965,374,659*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: ibuprofen

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,649,284Treating critically ill patients with intravenous ibuprofen► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ibuprofen

Country Document Number Estimated Expiration
South Korea20120138229► Subscribe
China102791268► Subscribe
South Korea20140014350► Subscribe
World Intellectual Property Organization (WIPO)2010105129► Subscribe
Canada2767971► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Fuji
McKinsey
Deloitte
Novartis
Cipla
Baxter
Colorcon
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot